Skip to main content
RT @DrPetryna: #EULAR2020 #op0192 UK Biobank and IMPALA studies: metabolic body composition of PsA pts w/increased VAT,e

Olga Petryna DrPetryna

6 years 4 months ago
#EULAR2020 #op0192 UK Biobank and IMPALA studies: metabolic body composition of PsA pts w/increased VAT,ectopic liver fat distribution & ⬆️ abdominal fat index associated w/increased risk of CHD&T2DM @RheumNow https://t.co/CwwAB2yUid
RT @DrPetryna: How often do you use MRI of peripheral joints for diagnosis or monitoring of PsA?

Olga Petryna DrPetryna

6 years 4 months ago
How often do you use MRI of peripheral joints for diagnosis or monitoring of PsA?
RT @DrPetryna: #EULAR2020 #op0182 delayed gadolinium-enhanced MRI study reveals proteoglycan loss in articulate cartilag

Olga Petryna DrPetryna

6 years 4 months ago
#EULAR2020 #op0182 delayed gadolinium-enhanced MRI study reveals proteoglycan loss in articulate cartilage in PsA associated w/severity of periarticular inflammation, synovitis &flexor tenosynovits but not bone erosion or prolypheration. @RheumNow https://t.co/ZJBDnZuYbB
RT @DrPetryna: #EULAR2020 #op0202-hpr 🇬🇧 study remind that resistant training benefits patients with inflammatory

Olga Petryna DrPetryna

6 years 4 months ago
#EULAR2020 #op0202-hpr 🇬🇧 study remind that resistant training benefits patients with inflammatory arthritides: improved function, wellbeing, self-efficacy, strength and fatigue.improved balance&endurance helps prevent falls @RheumNow https://t.co/MH7VD6zH9t
RT @DrPetryna: #EULAR2020 #op0143 a nationwide study concludes GCA pts at higher risk for sarcoma (HR 2.14), kidney canc

Olga Petryna DrPetryna

6 years 4 months ago
#EULAR2020 #op0143 a nationwide study concludes GCA pts at higher risk for sarcoma (HR 2.14), kidney cancer (1.6), hematological malignancies (HL2.42&non-HL1.66). Overall cancer HR 1.29. Time to diagnosis shorter in GCA (~48mo) vs controls (~58mo) @RheumNow https://t.co/obAlZw2gei
RT @DrPetryna: #EULAR2020 #op0148 real world European study of Mepolizumab in 142 pts w/EGPA shows significant improveme

Olga Petryna DrPetryna

6 years 4 months ago
#EULAR2020 #op0148 real world European study of Mepolizumab in 142 pts w/EGPA shows significant improvement of general, ENT, pulm&neuro symptoms. Significant reduction in BVAS, 90%decrease of asthma attacks by 12 mo, decreased steroid use. 21.1%non-serious AEs @RheumNow https://t.co/fN4tKPvUaE
RT @DrPetryna: #eular2020 #op0227 52 wk SEC vs ADA H2H EXCEED trial: Acr20 67.4%SEC vs 61.5%ADA. Better retention of SEC

Olga Petryna DrPetryna

6 years 4 months ago
#eular2020 #op0227 52 wk SEC vs ADA H2H EXCEED trial: Acr20 67.4%SEC vs 61.5%ADA. Better retention of SEC at 85.7% vs 76.3%ADA. SEC significantly outperforms in PASI90 (65.4 SEC be 43.2 ADA) @RheumNow https://t.co/M8UGydTFDF
RT @DrPetryna: #eular2020 #op0314 5 y drug-free remission (5DFR) is rare in early AxSpA: 17%pts from DESIR cohort reach

Olga Petryna DrPetryna

6 years 4 months ago
#eular2020 #op0314 5 y drug-free remission (5DFR) is rare in early AxSpA: 17%pts from DESIR cohort reach 5DFR. Shorter disease duration (<1.3y), lower BASDAI&ASAS-CRP & less peripheral involv more likely to achieve DFR. Imaging and biological data did not predict DFR @RheumNow
RT @DrPetryna: EULAR2020 #op0168 🇰🇷Population-based cohort study identifies both allopurinol&amp; febuxostat assoc

Olga Petryna DrPetryna

6 years 4 months ago
EULAR2020 #op0168 🇰🇷Population-based cohort study identifies both allopurinol& febuxostat associated with MI, cerebral infarction&cerebral hemorrhage. Fluctuation of sUA&potentially even cardiovascular gout attacks (urate crystals in vasculature) as possible causes @RheumNow https://t.co/mcb5NLnMq1
RT @DrPetryna: #EULAR2020 #op0028 12 wk ph3 RELIEF study: Apremilast effectively relieves OU pain and OU number after 12

Olga Petryna DrPetryna

6 years 4 months ago
#EULAR2020 #op0028 12 wk ph3 RELIEF study: Apremilast effectively relieves OU pain and OU number after 12 wks of 30 mg bid Rx. Great proportion of APR PTs achieved >10 mm &>30 mm improvement in OU pain @RheumNow https://t.co/p71sz9XL0e
RT @DrPetryna: #EULAR2020 #op0327 AI stages knee OA radiograpgic chsnges ieth accuracy 91.8-99% in 95% of the cases. Wou

Olga Petryna DrPetryna

6 years 4 months ago
#EULAR2020 #op0327 AI stages knee OA radiograpgic chsnges ieth accuracy 91.8-99% in 95% of the cases. Would you prefer AI or human radiology readings for MSK imaging ? @RheumNow
LVV=Large vessel vasculitis

Dr. John Cush RheumNow

6 years 4 months ago
LVV=Large vessel vasculitis
RT @drdavidliew: Do patients with early RA need to see a rheumatologist in the first 6w after Sx onset, or will 12w do?

David Liew drdavidliew

6 years 4 months ago
Do patients with early RA need to see a rheumatologist in the first 6w after Sx onset, or will 12w do? Getting in before 6w is better for drug-free remission than 12w, but not for radiographic progression - although >12w is too long! Leiden/ESPOIR OP0222 #EULAR2020 @RheumNow https://t.co/uaLsK4TMSR
RT @drdavidliew: Here's the data for GCA (even though labelled PMR) using the same methods, both looking at first 1y.

H

David Liew drdavidliew

6 years 4 months ago
Here's the data for GCA (even though labelled PMR) using the same methods, both looking at first 1y. Here's what gets me - it's obviously worse, but not that much worse... everyone's looking for steroid-sparing agents in GCA, but PMR's left behind? OP0275 #EULAR2020 @RheumNow https://t.co/YWkNBVitGa
RT @drdavidliew: For your new diagnosis RA patients, how long have they typically had symptoms for by the time they firs

David Liew drdavidliew

6 years 4 months ago
For your new diagnosis RA patients, how long have they typically had symptoms for by the time they first see you? #EULAR2020 @RheumNow
×